Fala, L. (2015). Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes. Am Health Drug Benefits.
Style de citation ChicagoFala, Loretta. "Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients With Type 2 Diabetes." Am Health Drug Benefits 2015.
Style de citation MLAFala, Loretta. "Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients With Type 2 Diabetes." Am Health Drug Benefits 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.